The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes
Open accessAbstract
OBJECTIVE: Vasculoprotective endothelial progenitor cells (EPCs) are regulated by stromal-derived factor-1α (SDF-1α) and are reduced in type 2 diabetes. Because SDF-1α is a substrate of dipeptidyl-peptidase-4 (DPP-4), we investigated whether the DPP-4 inhibitor sitagliptin modulates EPC levels in type 2 diabetic patients. RESEARCH DESIGN AND METHODS: This was a controlled, nonrandomized clinical trial comparing 4-week sitagliptin (n = 16) versus no additional treatment (n = 16) in addition to metformin and/or secretagogues in type 2 diabetic patients. We determined circulating EPC levels and plasma concentrations of SDF-1α, monocyte chemoattractant protein-1 (MCP-1), vascular endothelial growth factor (VEGF), and nitrites/nitrates. RESULTS: There was no difference in clinical baseline data between the sitagliptin and control arms. After 4 weeks, as compared with control subjects, patients receiving sitagliptin showed a significant increase in EPCs and SDF-1α and a decrease in MCP-1. CONCLUSIONS: Sitagliptin increases circulating EPCs in type 2 diabetic patients with concomitant upregulation of SDF-1α. This ancillary effect of DPP-4 inhibition might have potential favorable cardiovascular implications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600
Circulating endothelial progenitor cells and cardiovascular outcomes
Werner, N., Kosiol, S., Schiegl, T., Ahlers, P., Walenta, K., Link, A., Böhm, M., & Nickenig, G. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043814 · Cited by 2,048
Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells
Aicher, A., Heeschen, C., Mildner-Rihm, C., Urbich, C., Ihling, C., Technau-Ihling, K., Zeiher, A. M., & Dimmeler, S. (2003) · Nature Medicine · doi:10.1038/nm948 · Cited by 1,305
Ban, K., Noyan-Ashraf, M. H., Hoefer, J., Bolz, S.-S., Drucker, D. J., & Husain, M. (2008) · Circulation · doi:10.1161/circulationaha.107.739938 · Cited by 1,057
Fadini, G. P., Miorin, M., Facco, M., Bonamico, S., Baesso, I., Grego, F., Menegolo, M., de Kreutzenberg, S. V., Tiengo, A., Agostini, C., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.067 · Cited by 726
Self-citationFadini, G. P., Sartore, S., Albiero, M., Baesso, I., Murphy, E., Menegolo, M., Grego, F., Vigili de Kreutzenberg, S., Tiengo, A., Agostini, C., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000237750.44469.88 · Cited by 421
Self-citationZaruba, M.-M., Theiss, H. D., Vallaster, M., Mehl, U., Brunner, S., David, R., Fischer, R., Krieg, L., Hirsch, E., Huber, B., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.02.013 · Cited by 301
Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia–reperfusion injury in rats
Fadini, G. P., Sartore, S., Schiavon, M., Albiero, M., Baesso, I., Cabrelle, A., Agostini, C., & Avogaro, A. (2006) · Diabetologia · doi:10.1007/s00125-006-0401-6 · Cited by 255
Self-citationEndothelial progenitor cells in the natural history of atherosclerosis
Fadini, G. P., Agostini, C., Sartore, S., & Avogaro, A. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.046 · Cited by 193
Self-citationProost, P., Struyf, S., Schols, D., Durinx, C., Wuyts, A., Lenaerts, J.-P., De Clercq, E., De Meester, I., & Van Damme, J. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00830-8 · Cited by 193
Significance of Endothelial Progenitor Cells in Subjects With Diabetes
Fadini, G. P., Sartore, S., Agostini, C., & Avogaro, A. (2007) · Diabetes Care · doi:10.2337/dc06-2305 · Cited by 190
Self-citationFadini, G. P., Boscaro, E., de Kreutzenberg, S., Agostini, C., Seeger, F., Dimmeler, S., Zeiher, A., Tiengo, A., & Avogaro, A. (2010) · Diabetes Care · doi:10.2337/dc09-1999 · Cited by 186
Self-citationLow CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes
Fadini, G. P., de Kreutzenberg, S., Agostini, C., Boscaro, E., Tiengo, A., Dimmeler, S., & Avogaro, A. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.03.040 · Cited by 110
Self-citationHumpert, P. M., Neuwirth, R., Battista, M. J., Voronko, O. E., von Eynatten, M., Konrāde, I., Rudofsky, G., Wendt, T., Hamann, A., Morcos, M., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.934 · Cited by 60
Cited by
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
Mulvihill, E. E., & Drucker, D. J. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1035 · Cited by 609
Nauck, M. A., Meier, J. J., Cavender, M. A., Abd El Aziz, M., & Drucker, D. J. (2017) · Circulation · doi:10.1161/circulationaha.117.028136 · Cited by 582
Macro‐ and microvascular endothelial dysfunction in diabetes: 糖尿病诱导的内皮细胞功能损伤
Shi, Y., & Vanhoutte, P. M. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12521 · Cited by 545
Cardiovascular Biology of the Incretin System
Ussher, J. R., & Drucker, D. J. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1052 · Cited by 530
The Treatment of Impaired Wound Healing in Diabetes: Looking among Old Drugs
Spampinato, S. F., Caruso, G. I., De Pasquale, R., Sortino, M. A., & Merlo, S. (2020) · Pharmaceuticals · doi:10.3390/ph13040060 · Cited by 468
Metadata
- Authors
- Fadini, G. P., Boscaro, E., Albiero, M., Menegazzo, L., Frison, V., de Kreutzenberg, S., Agostini, C., Tiengo, A., & Avogaro, A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-03-31
- Volume
- 33
- Issue
- 7
- Pages
- 1607-1609
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2158498099
- Cited by
- 318
- References
- 14
- FWCI
- 18.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.